InMed Pharmaceuticals Inc. (INM) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

InMed Pharmaceuticals Inc. (INM) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $3.0M, listed on NASDAQ, employing roughly 13 people, carrying a beta of 0.57 to the broader market. InMed Pharmaceuticals Inc. Led by Eric A. Adams Chem., public since 2014-05-05.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for INM as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →